They are funded through until at least mid next year by which time they will have results of three phase 2 trials. The most important milestone this year is the interim data release for SNT 5505 in myelofibrosis - and a presentation at ASH in December. Spec buy and hold until then in my opinion.
- Forums
- ASX - By Stock
- SNT
- Ann: Phase 2 Trial Reaches 50% Recruitment
Ann: Phase 2 Trial Reaches 50% Recruitment, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.95M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $17.03K | 420.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 70774 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 250000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 70774 | 0.040 |
8 | 512040 | 0.039 |
3 | 430000 | 0.038 |
1 | 100000 | 0.037 |
3 | 500099 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 250000 | 1 |
0.043 | 34039 | 1 |
0.045 | 145224 | 2 |
0.047 | 33889 | 1 |
0.049 | 25000 | 1 |
Last trade - 11.39am 18/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |